Viewing Study NCT05708950


Ignite Creation Date: 2025-12-24 @ 5:20 PM
Ignite Modification Date: 2025-12-27 @ 1:17 PM
Study NCT ID: NCT05708950
Status: UNKNOWN
Last Update Posted: 2023-07-13
First Post: 2022-12-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Sponsor: Kineta Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: VISTA-101
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View